Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents

Luteinizing hormone-releasing hormone receptor agonists and antagonists in prostate cancer: effects on long-term survival and combined therapy with next-generation hormonal agents

Prostate cancer is a leading cause of cancer-related death in men worldwide. Luteinizing hormone-releasing hormone receptor (LHRH-R) agonists and antagonists are known to achieve castration-level testosterone suppression; however, long-term data comparing the survival benefits of these therapies are...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jinge Zhao, Junru Chen, Guangxi Sun, Pengfei Shen, Hao Zeng
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2024-11-01
Series:	Cancer Biology & Medicine
Subjects:	luteinizing hormone-releasing hormone receptor agonists luteinizing hormone-releasing hormone receptor antagonists prostate cancer long-term survival next-generation hormonal agents
Online Access:	https://www.cancerbiomed.org/content/21/11/1012
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

HORMONE THERAPY WITH USAGE OF AGONISTS AND ANTAGONISTS OF LUTEINIZING HORMONE RELEASING HORMONE IN PATIENTS WITH PROSTATE CANCER
by: K. M. Nyushko, et al.
Published: (2015-01-01)

Luteinizing hormone profiles during ovarian stimulation in assisted reproductive treatment
by: Hannah Verschuere, et al.
Published: (2024-12-01)

Association of the Effect of Alcohol Consumption on Luteinizing Hormone (LH), Follicle-Stimulating Hormone (FSH), and Testosterone Hormones in Men: A Systematic Review and Meta-Analysis
by: Mahmood Moosazadeh, et al.
Published: (2024-12-01)

The role of luteinizing hormone activity in spermatogenesis: from physiology to clinical practice
by: Sandro C. Esteves, et al.
Published: (2025-01-01)

Effect of Toxoplasma gondii Infection on the Level of Luteinizing and Follicle Stimulating Hormones in Women with Polycystic Ovary Syndrome
by: Muna Jalal Aziz, et al.
Published: (2024-10-01)

Role of Inhibin B and Ratio of Luteinizing: Follicle-Stimulating Hormones in Phenotyping Polycystic Ovarian Syndrome
by: Zainab G. Falh, et al.
Published: (2024-12-01)

Management Infertility by Hormones Replacement Therapy in Women with Polycystic Ovarian Syndrome
by: Sardar Qadir Omer, et al.
Published: (2020-06-01)

EFFECTIVENESS OF HORMONAL TREATMENT IN PATIENTS WITH COMBINED ENDOMETRIAL PATHOLOGY AND BENIGN FORMATIONS OF MAMMARY GLANDS
by: Yu. S. Shapoval
Published: (2022-12-01)

Luteinizing hormone supplementation in assisted-reproduction technology: A bibliometric analysis of research hotspots and trends
by: Mei Liu, et al.
Published: (2025-01-01)

Exploring the therapeutic potential of Asparagus africanus in polycystic ovarian syndrome: a computational analysis
by: Riaz Sania, et al.
Published: (2024-12-01)

The effect of dienogest and gonadotropin-releasing hormone agonist on pelvic pain after laparoscopic surgery for endometriosis: An RCT
by: Fatemeh Davari Tanha, et al.
Published: (2025-02-01)

Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer
by: Shuqin Dai, et al.
Published: (2024-12-01)

Multiplex analysis platform for evaluation of endocrine disruption of emerging contaminants against human steroid hormone receptors using autobioluminescent yeast bioassay: Application to bisphenols
by: Yuan Huang, et al.
Published: (2024-12-01)

Hormone Receptors in Cervicovaginal Cells
by: Şayeste Demirezen, et al.
Published: (2013-04-01)

Luteinizing hormone is independently associated with high‐sensitive cardiac troponin T elevation in postmenopausal T2DM patients: A cross‐sectional study
by: Yahao Wang, et al.
Published: (2024-10-01)

Effect of body mass index on progesterone level on trigger day in gonadotropin-releasing hormone antagonist cycles
by: Yating Sun, et al.
Published: (2024-12-01)

Impact of Gonadotropin-releasing Hormone Analogue and Gender-affirming Hormone Therapy on Bone Mineral Density in Transgender Adolescents
by: Marta Chuncia, et al.
Published: (2025-01-01)

Effect of basal luteinizing hormone/follicle-stimulating hormone ratio on clinical outcome of In Vitro fertilization in patients with polycystic ovarian syndrome: a retrospective cohort study
by: Dan Shan, et al.
Published: (2024-11-01)

A Case of Thyroid Hormone Resistance Syndrome with a Novel Mutation (c.947G>a) in the THRB Gene: Experience in Diagnosis and Treatment
by: Liu J, et al.
Published: (2024-11-01)

Serum Mannose Level and Its Association in Women with Polycystic Ovarian Syndrome: a Case Control Study of Al-Najaf City / 2020
by: Basima Shamkhi Al Ghazali, et al.
Published: (2022-06-01)

Effect of central administration of indomethacin on anandamide-induced GnRH/LH secretion in the hypothalamus of anoestrous ewes
by: Tomaszewska-Zaremba Dorota, et al.
Published: (2024-07-01)

Diagnostic Criteria of Growth Hormone Deficiency Needs to be Reevaluated
by: Enes Salı, et al.
Published: (2012-12-01)

Lower serum LH level was related to poor embryo quality and adverse pregnancy outcomes in fixed GnRH antagonist protocol with estradiol pretreatment
by: Ying Chen, et al.
Published: (2024-12-01)

Endocrine predictors of testicular biopsy efficacy in patients with azoospermia
by: V. A. Toropov, et al.
Published: (2017-06-01)

Hormonal interventions in skin wounds – a mini review
by: Zeming Li, et al.
Published: (2024-11-01)

Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial
by: Fumio Otsuka, et al.
Published: (2025-02-01)

Clinical parameters that predict a premature LH rise in patients undergoing ovarian stimulation for IVF
by: Maya Nasatzky, et al.
Published: (2024-12-01)

Terapia hormonal con compuestos de hormonas bioidénticas y bioética
by: Manuel R. García-Sáenz, et al.
Published: (2024-01-01)

Effect of Cucurbita pepo (Pumpkin) seed extracts on the cyclicity and reproductive hormones of female Wistar rats
by: Chinwe Fiona Anyanwu, et al.
Published: (2024-10-01)

Potential therapeutic efficacy of photodynamic therapy on female hormonal-dependent cancers in a hormonal simulated microenvironment
by: Ellie Shihng-meir Chu, et al.
Published: (2024-02-01)

Growth hormone receptor promotes osteosarcoma cell growth and metastases
by: Mo Cheng, et al.
Published: (2020-01-01)

Hypothalamic corticotropin-releasing hormone neurons modulate sevoflurane anesthesia and the post-anesthesia stress responses
by: Shan Jiang, et al.
Published: (2024-11-01)

Growth Hormone Deficiency
by: Ömer Tarım, et al.
Published: (2010-05-01)

Gonadal Hormone Changes with Aging and Their Impact on Chronic Pain
by: Onella Athnaiel, et al.
Published: (2025-01-01)

Therapeutic role of isoflavones from traditional medicine in the management of polycystic ovary syndrome
by: Ashwini Armarkar, et al.
Published: (2025-03-01)

Alterations in the polarization of liver M1/M2 macrophages upon long-term administration of triptorelin in rats
by: M.V. Rud, et al.
Published: (2024-11-01)

Spuriously low thyroid-stimulating hormone? A laboratory phenomenon
by: S Danalakshmi, et al.
Published: (2022-01-01)

Role of Growth Hormone Therapy in Metabolic-Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis
by: Deep Dutta, et al.
Published: (2024-08-01)

The effect of strength training at different times of stress on some physiological and hormonal indicators in untrained men
by: Yazdan Foroutan, et al.
Published: (2020-08-01)

Relationship between the Stimulated Peak Growth Hormone Level and Metabolic Parameters in Children with Growth Hormone Deficiency
by: Seong Yong Lee
Published: (2023-01-01)